|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMGP01011215
|
PC 3:0/3:0
|
1,2-dipropionyl-sn-glycero-3-phosphocholine
|
PC 6:0
|
C14H28NO8P
|
369.155255
|
|
LMGP20010053
|
PC 0:0/20:4;O)
|
2-(15R-hydroxy-5Z,8Z,12E,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine
|
LPC 20:4;O
|
C28H50NO8P
|
559.327405
|
|
LMGP20010053
|
PC 0:0/20:4;O)
|
2-(15R-hydroxy-5Z,8Z,12E,14Z-eicosatetraenoyl)-sn-glycero-3-phosphocholine
|
LPC 20:4;O
|
C28H50NO8P
|
559.327405
|
|
LMGP04010035
|
PG 12:0/12:0
|
1,2-didodecanoyl-sn-glycero-3-phospho-(1'-sn-glycerol)
|
PG 24:0
|
C30H59O10P
|
610.384587
|
|
LMGP15010195
|
PIM5(16:0/16:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1,2-dihexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
|
PIM5 32:0
|
C71H129O38P
|
1620.789958
|
|
LMGP15010243
|
PIM6(16:0/16:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1,2-dihexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
|
PIM6 32:0
|
C77H139O43P
|
1782.842783
|
|
LMGP06010820
|
PI 21:0/21:0
|
1,2-diheneicosanoyl-sn-glycero-3-phospho-(1'-myo-inositol)
|
PI 42:0
|
C51H99O13P
|
950.682332
|
|
LMGP06010861
|
PI 17:2(9Z,12Z)/17:2(9Z,12Z)
|
1,2-di-(9Z,12Z-heptadecadienoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
|
PI 34:4
|
C43H75O13P
|
830.494532
|
|
LMGP01010937
|
PC 18:2(9Z,12Z)/18:2(9Z,12Z)
|
1,2-di-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine
|
PC 36:4
|
C44H80NO8P
|
781.562156
|
|
LMGP01012148
|
PC 18:1(11Z)/18:1(9Z)
|
1-(11Z-octadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine
|
PC 36:2
|
C44H84NO8P
|
785.593456
|
|
LMGP02011277
|
PE 14:0(12Me[S])/14:0(13Me)
|
1-(12S-methyltetradecanoyl)-2-(13-methyltetradecanoyl)-sn-glycero-3-phosphoethanolamine
|
PE 30:0
|
C35H70NO8P
|
663.483906
|
|
LMGP03010498
|
PS 19:1(9Z)/19:1(9Z)
|
1,2-di-(9Z-nonadecenoyl)-sn-glycero-3-phosphoserine
|
PS 38:2
|
C44H82NO10P
|
815.567636
|
|
LMGP03010851
|
PS 21:0/21:0
|
1,2-diheneicosanoyl-sn-glycero-3-phosphoserine
|
PS 42:0
|
C48H94NO10P
|
875.661536
|
|
LMGP04010498
|
PG 19:1(9Z)/19:1(9Z)
|
1,2-di-(9Z-nonadecenoyl)-sn-glycero-3-phospho-(1'-sn-glycerol)
|
PG 38:2
|
C44H83O10P
|
802.572387
|
|
LMGP04010611
|
PG 20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z)
|
1,2-di-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phospho-(1'-sn-glycerol)
|
PG 40:6
|
C46H79O10P
|
822.541087
|
|
LMGP04010956
|
PG 18:2(9Z,12Z)/18:2(9Z,12Z)
|
1,2-di-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-(1'-sn-glycerol)
|
PG 36:4
|
C42H75O10P
|
770.509787
|
|
LMGP15010147
|
PIM4(16:0/16:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1,2-dihexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
|
PIM4 32:0
|
C65H119O33P
|
1458.737133
|
|
LMGP06010008
|
PI 18:0/18:0
|
1,2-dioctadecanoyl-sn-glycero-3-phospho-(1'-myo-inositol)
|
PI 36:0
|
C45H87O13P
|
866.588432
|
|
LMGP06010466
|
PI 19:1(9Z)/19:1(9Z)
|
1,2-di-(9Z-nonadecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
|
PI 38:2
|
C47H87O13P
|
890.588432
|
|
LMGP06010547
|
PI 20:2(11Z,14Z)/20:2(11Z,14Z)
|
1,2-di-(11Z,14Z-eicosadienoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
|
PI 40:4
|
C49H87O13P
|
914.588432
|
|
LMGP06010915
|
PI 22:0/22:0
|
1,2-didocosanoyl-sn-glycero-3-phospho-(1'-myo-inositol)
|
PI 44:0
|
C53H103O13P
|
978.713632
|
|
LMGP06010938
|
PI 16:1(9Z)/16:1(9Z)
|
1,2-di-(9Z-hexadecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
|
PI 32:2
|
C41H75O13P
|
806.494532
|
|
LMGP03010985
|
PS 22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)
|
1,2-di-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-phosphoserine
|
PS 44:12
|
C50H74NO10P
|
879.505036
|
|
LMGP03010381
|
PS 18:3(6Z,9Z,12Z)/18:3(9Z,12Z,15Z)
|
1-(6Z,9Z,12Z-octadecatrienoyl)-2-(9Z,12Z,15Z-octadecatrienoyl)-glycero-3-phosphoserine
|
PS 36:6
|
C42H70NO10P
|
779.473736
|
|
LMGP04010980
|
PG 18:3(9Z,12Z,15Z)/18:3(9Z,12Z,15Z)
|
1,2-di-(9Z,12Z,15Z-octadecatrienoyl)-sn-glycero-3-phospho-(1'-sn-glycerol)
|
PG 36:6
|
C42H71O10P
|
766.478487
|
|
LMGP02010345
|
PE-NMe(20:0/20:0)
|
1,2-dieicosanoyl-sn-glycero-3-phospho-N-methylethanolamine
|
PE-NMe 40:0
|
C46H92NO8P
|
817.656056
|
|
LMGP23010004
|
PEth 18:1(9Z)/18:1(9Z)
|
1,2-di-(9Z-octadecenoyl)--sn-glycero-3-phosphoethanol
|
PEth 36:2
|
C41H77O8P
|
728.535607
|
|
LMGP06010579
|
PI 20:3(8Z,11Z,14Z)/20:3(8Z,11Z,14Z)
|
1,2-di-(8Z,11Z,14Z-eicosatrienoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
|
PI 40:6
|
C49H83O13P
|
910.557132
|
|
LMGP06010862
|
PI 17:1(9Z)/17:1(9Z)
|
1,2-di-(9Z-heptadecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
|
PI 34:2
|
C43H79O13P
|
834.525832
|
|
LMGP06010966
|
PI 18:1(9Z)/18:1(9Z)
|
1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1'-myo-inositol)
|
PI 36:2
|
C45H83O13P
|
862.557132
|
|
LMGP01010964
|
PC 18:4(9Z,11E,13E,15Z)/18:4(9Z,11E,13E,15Z)
|
1,2-di-(9Z,11E,13E,15Z-octadecatetraenoyl)-sn-glycero-3-phosphocholine
|
PC 36:8
|
C44H72NO8P
|
773.499556
|
|
LMGP03010023
|
PS 18:2(9Z,12Z)/18:2(9Z,12Z)
|
1,2-di-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphoserine
|
PS 36:4
|
C42H74NO10P
|
783.505036
|
|
LMGP15010066
|
PIM2(18:0/18:0)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1,2-dioctadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
|
PIM2 36:0
|
C57H107O23P
|
1190.694083
|
|
LMGP15010003
|
PIM1(16:0/16:0)
|
2'-O-(alpha-D-Manp)-(1,2-dihexadecanoyl-sn-glycero-3-phospho-1'-myo-inositol)
|
PIM1 32:0
|
C47H89O18P
|
972.578657
|
|
LMGP03010816
|
PS 22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)
|
1,2-di-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycero-3-phosphoserine
|
PS 44:8
|
C50H82NO10P
|
887.567636
|
|
LMGP04010752
|
PG 22:1(11Z)/22:1(11Z)
|
1,2-di-(11Z-docosenoyl)-sn-glycero-3-phospho-(1'-sn-glycerol)
|
PG 44:2
|
C50H95O10P
|
886.666287
|
|
LMGP01012095
|
PC 22:4(7Z,10Z,13Z,16Z)/22:4(7Z,10Z,13Z,16Z)
|
1,2-di-(7Z,10Z,13Z,16Z-docosatetraenoyl)-sn-glycero-3-phosphocholine
|
PC 44:8
|
C52H88NO8P
|
885.624756
|
|
LMGP03010030
|
PS 18:1(9Z)/18:1(9Z)
|
1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phosphoserine
|
PS 36:2
|
C42H78NO10P
|
787.536336
|
|
LMGP03010891
|
PS 17:1(9Z)/17:1(9Z)
|
1,2-di-(9Z-heptadecenoyl)-sn-glycero-3-phosphoserine
|
PS 34:2
|
C40H74NO10P
|
759.505036
|
|
LMGP04010860
|
PG 20:1(11Z)/20:1(11Z)
|
1,2-di-(11Z-eicosenoyl)-sn-glycero-3-phospho-(1'-sn-glycerol)
|
PG 40:2
|
C46H87O10P
|
830.603687
|
|
LMGP15010025
|
PIM1 18:1(9Z)/18:1(9Z)
|
2'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
|
PIM1 36:2
|
C51H93O18P
|
1024.609957
|
|
LMGP04010920
|
PG 14:1(9Z)/14:1(9Z)
|
1,2-di-(9Z-tetradecenoyl)-sn-glycero-3-phospho-(1'-sn-glycerol)
|
PG 28:2
|
C34H63O10P
|
662.415887
|
|
LMGP15010073
|
PIM2 18:1(9Z)/18:1(9Z)
|
2'-O-(alpha-D-Manp)-6'-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-2-(9Z-octadecenoyl)-sn-glycero-3-phospho-1'-myo-inositol)
|
PIM2 36:2
|
C57H103O23P
|
1186.662783
|
|
LMGP02010344
|
PE-NMe(18:0/18:0)
|
1,2-dioctadecanoyl-sn-glycero-3-phospho-N-methylethanolamine
|
PE-NMe 36:0
|
C42H84NO8P
|
761.593456
|
|
LMGP06010947
|
PI 15:0/15:0
|
1,2-dipentadecanoyl-sn-glycero-3-phospho-(1'-myo-inositol)
|
PI 30:0
|
C39H75O13P
|
782.494532
|
|
LMGP01011072
|
PC 21:0/21:0
|
1,2-diheneicosanoyl-sn-glycero-3-phosphocholine
|
PC 42:0
|
C50H100NO8P
|
873.718656
|
|
LMGP03010441
|
PS 18:4(6Z,9Z,12Z,15Z)/18:4(6Z,9Z,12Z,15Z)
|
1,2-di-(6Z,9Z,12Z,15Z-octadecatetraenoyl)-sn-glycero-3-phosphoserine
|
PS 36:8
|
C42H66NO10P
|
775.442436
|
|
LMGP03010671
|
PS 20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)
|
1,2-di-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-sn-glycero-3-phosphoserine
|
PS 40:10
|
C46H70NO10P
|
827.473736
|
|
LMGP03010752
|
PS 22:1(11Z)/22:1(11Z)
|
1,2-di-(11Z-docosenoyl)-sn-glycero-3-phosphoserine
|
PS 44:2
|
C50H94NO10P
|
899.661536
|
|
LMGP03010943
|
PS 22:0/22:0
|
1,2-didocosanoyl-sn-glycero-3-phosphoserine
|
PS 44:0
|
C50H98NO10P
|
903.692836
|